oxymorphone prodrug + PF-05 (Signature Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameoxymorphone prodrug + PF-05 (Signature Therapeutics)

Drug Alias NamePF-03 programoxymorphone prodrug + PF-05 (PharmacoFore)oxymorphone prodrug + PF-05 (Signature Therapeutics)oxymorphone prodrug + PF-05 (PharmacoFore)

ClassificationSmall molecules

Mechanisms of ActionOpioid receptors modulators

TargetsOpioid receptors

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSignature Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSignature Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsPain

Other Information

ATC CodeN/A